#pharmaceutical manufacturing companies
FEATURED RESOURCES. Infographics
Psoriasis was recognized for the first time as a serious non-communicable disease at the World Health Assembly in 2014. To help bring the public health impact of psoriasis into focus and to help raise awareness of the range of ways that psoriasis can affect peoples’ lives, IFPMA presents the recommendations.
OTHER RESOURCES. Infographics
FEATURED RESOURCES. Videos
The session that took place at 2016 GHF Shaping a sound supply chain ecosystem gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential.
OTHER RESOURCES. Videos
FEATURED RESOURCES. News Releases
Brazzaville/Kigali, 11 May 2016 – Ongoing efforts to prevent and control cervical cancer in the African Region have received a significant boost following the announcement of a pioneering partnership between the World Health Organization African Region (WHO AFRO) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). The.
OTHER RESOURCES. News Releases
FEATURED RESOURCES. Interviews
IFPMA 2016 interview series on The R D challenges in tackling Zika virus As part of our latest interview series, we sat down with Dr. Ted Tsai to discuss the current R D challenges in the fight against Zika virus. Dr. Ted Tsai, a vaccine expert from Takeda, took part in.
OTHER RESOURCES. Interviews
FEATURED RESOURCES. Statements
ABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) have today issued a joint.
OTHER RESOURCES. Statements
There are many challenges in improving public health policy for current and future generations. To play an effective role in advancing these policies, the research-based biopharmaceutical industry needs an informed and credible voice in the conversation with the global health community. That voice is IFPMA.
By Mario Ottiglio
This blog was originally posted in Diplomatic Courier Since the start of this millennium, we have witnessed many success stories in global health. Death from infectious diseases like malaria and tuberculosis have been cut in half. A child is twice as likely to survive past their fifth birthday than he or she was fifteen year ago. Hunger and malnutrition remain, but affect a smaller percentage of.
By Pierre Van Damme
Viral hepatitis – a silent, but preventable epidemic Recent breakthroughs in available treatment options and the broader objectives of the health-related Sustainable Development Goals (SGDs) make the WHO target of eliminating viral hepatitis by 2030 feasible. Earlier this week, the WHO issued updated guidelines for the treatment of hepatitis C infection, to “promote the transition to newer, more effective medicines that have the potential to.
By Paul Stoffels
It seems there is always a new story in the media about an emerging health threat. Right now, understandably, there is significant public concern about the spread of the Zika virus. But just over a year ago, it was the Ebola virus and its devastating impact in West Africa that dominated the headlines. The Ebola epidemic in West Africa may have subsided, but not after.